Kisqali 600 MG daily dose 63S
Ended Awarded
- Contract number
- SPE2DB25FJU02
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $107,061
Award facts
- Contract value 100% obligated
- $107,060.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $107,060.62 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Kisqali 600 mg daily dose tablets (63-count units). This is a non-set-aside competitive award with an ultimate completion date of September 5, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's substantial pharmaceutical supply relationship with the federal government, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This award is issued as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. Kisqali, a specialized oncology medication, reflects the breadth of therapeutic domains covered under the company's federal contract portfolio, which encompasses diabetes medications, neurological treatments, pain management pharmaceuticals, and other critical medical commodities serving the Defense Health Agency and related federal healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FJU02?
SPE2DB25FJU02 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FJU02 worth?
The government has obligated $107,061 on SPE2DB25FJU02.
Is contract SPE2DB25FJU02 an order under another contract?
Yes. SPE2DB25FJU02 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJU02 competed?
The extent of competition for SPE2DB25FJU02 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award